Clinical Trial Update: Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating different doses of thalidomide in transfusion-dependent beta-thalassemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• Thalomid (thalidomide)

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Fetal Hemoglobin, Thalassemia Major | Phase 2 | Status: RECRUITING